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The use of transgenic crops expressing one or 
more crystal (Cry) proteins for insect management 
has grown dramatically since their introduction 
nearly 2 decades ago. However, many questions 
surrounding the environmental fate of these proteins 
still persist. One area of particular interest is the 
possible detection of Cry protein fragments by 
the antibodies used in ELISA kits. A model system 
approach is used to generate environmentally 
relevant fragments by simulating conditions and 
digestive enzymes that are known to exist in 
environments in which Cry proteins may be present. 
Seven different types of model systems were 
screened for their ability to generate fragments of the 
Cry1Ab protein; five of these model systems reliably 
generated Cry1Ab fragments. These fragments 
were analyzed in a subsequent study to determine 
whether the fragments were still detectable by ELISA 
and whether they retained any bioactivity.
Insecticidal crystal (Cry) proteins isolated from the bacterium Bacillus thuringiensis are widely used for insect pest management in agriculture. Since their introduction in 1996, 
transgenic maize expressing one or more Cry proteins now 
accounts for 81% of all maize planted in the United States (1). Such 
widespread use has led to questions regarding the environmental 
fate of Cry proteins, including persistence, movement, and 
stability, in various environmental matrixes.
Many researchers are addressing these questions by attempting 
to detect and quantify the amount of Cry proteins in environmental 
samples. Various detection methods are used to monitor for Cry 
proteins in environmental samples, but the most commonly used 
method is ELISA (2). Microtiter plate ELISAs are preferred 
to methods such as western blotting, because the ELISA kits 
typically include all required materials; a large number of samples 
typically are processed in a short amount of time (4–8 h) and with 
little specialized training, making them very cost effective for 
researchers in academia and industry (2).
Several manufacturers produce ELISA kits for detection of Cry 
proteins, primarily for seeds and leaf tissue. Before ELISA kits are 
used for detection of Cry proteins in environmental samples, the 
entire analytical method (including the extraction protocol) must 
be validated. A quality validation study addresses the following: 
(1) sensitivity—defining the quantitative range and determining 
the upper and lower LOQ; (2) specificity—determining that 
only the protein of interest is detected and that there is no cross-
reactivity or interference with related proteins or components 
in the matrix; (3) accuracy—ensuring that the method has high 
extraction efficiency and can recover a majority of the protein in 
the sample matrix; and (4) precision—ensuring that the results are 
repeatable across days, analysts, and laboratories. These steps are 
well researched and common in the literature (3–5).
Despite these steps, biological validation, i.e., ensuring that the 
proteins detected are bioactive, is usually lacking. This is a crucial 
oversight, because a majority of the ELISA kits use polyclonal 
antibodies. Polyclonal antibodies are produced by injecting 
the antigen of interest into a vertebrate host organism and later 
purifying the antibodies out of the serum. The process results in a 
heterogeneous mixture of antibodies that bind to multiple epitopes 
on a protein, increasing the chances of detection and leading to 
very sensitive assays. However, the use of polyclonal antibodies 
also increases the likelihood of a false-positive result through the 
detection of a partially degraded protein. Although some antibody-
binding sites on a partially degraded protein (fragment) may have 
lost functionality, other antibodies in the heterogeneous mixture 
may still be capable of binding to the protein fragment. This 
could result in an ELISA test indicating a positive detection and 
quantification of a Cry protein in a sample in which no fully intact 
protein exists. False-positive results may lead to overestimations 
of the concentrations of these proteins in the environment, which 
potentially could impact the risk assessment for these proteins.
This phenomenon of Cry protein fragments producing false-
positive results is well known. Einspanier et al. (6) fed transgenic 
maize to cattle to trace select proteins through the bovine 
gastrointestinal tract (GIT) using a commercially available 
ELISA kit. They reported that Cry1Ab protein accumulated 
during the pass through the GIT; cross-reactivity with other 
proteins or matrix interference was not the cause, because the 
effect was not observed in cattle fed isoline, nontransgenic 
maize (6). In a subsequent study, the authors hypothesized that 
the protein was fragmented, yet still immunoactive, leading to its 
detection (7). This hypothesis was tested by feeding transgenic 
maize containing Cry1Ab to cattle, collecting samples from 
the GIT at slaughter, and analyzing them with ELISAs and 
western blotting. The ELISA results indicated that the Cry1Ab 
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concentration increased during passage through the GIT. 
However, the western blotting results showed that no Cry1Ab 
was present in any samples; only bands of approximately 34 and 
17 kDa were observed, whereas the source Cry1Ab was 60 kDa, 
calling into question the ELISA results (7). Therefore, it is 
crucial to understand how fragmented proteins affect ELISAs 
and to determine whether any bioactivity is retained by these 
fragments.
To determine whether Cry protein fragments are still detectable 
by ELISAs, a reliable and reproducible method of generating 
Cry protein fragments must first be developed. The objective of 
this study is to use a model system approach to degrade Cry1Ab 
protein into environmentally relevant fragments. A model system 
approach is useful because it allows researchers to control all 
parameters in a system; one or several parameters can then 
be altered to determine the effects that changes would have on 
the system as a whole. In this study, the use of a model system 
approach allows Cry1Ab to be degraded in a controlled manner 
and to produce environmentally relevant fragments. Four enzyme-
based model systems using the enzymes trypsin, chymotrypsin, 
pepsin, and proteinase K were evaluated. Nonenzyme-based model 
systems, including photodegradation, acidic buffer, and long-term 
degradation in buffer, were also tested for their ability to generate 
fragments of Cry1Ab. Gel electrophoresis with Coomassie or 
silver staining was used to confirm fragmentation of the protein. 
Bioassays were performed on model system components to ensure 
that these components would not have a significant effect on insect 
survival or weight gain.
Experimental
Apparatus and Materials
(a) Gel electrophoresis system.—Bio-Rad Mini-Protean II 
gel apparatus (gel size, 8.3 mm × 7.3 mm × 1 mm) and Bio-Rad 
Power Pac 1000 (Hercules, CA).
(b) Centrifuge.—Spectrafuge 24D, Labnet International, 
Inc. (Edison, NJ).
(c) Gel digitization system.—Lexmark X83 all-in-one 
printer/copier/scanner and Lexmark Viewing Booth software 
(Lexmark International, Inc., Lexington, KY) were used to 
digitize the gels. Adobe Photoshop CS5 (version 12.1 x64) 
(Adobe System, Inc., San Jose, CA) was used to edit and 
annotate the gels.
(d) Orbital shaker.—ELMI, Ltd (Riga, Latvia).
(e) Photoreactor.—Rayonet® photoreactor (Southern New 
England UV Co., Branford, CT) with 254 or 365 nm lamps. 
A Pyrex test tube was used with the 254 nm lamp and a quartz 
cuvette was used with the 365 nm lamp.
(f) pH Meter.—Fisher Accumet pH meter Model 805 MP 
(Fisher Scientific, Pittsburgh, PA).
Reagents
(a) Chemicals.—Acetic acid, ammonium persulfate, 
bromophenol blue, butanol, calcium chloride, Coomassie Brilliant 
Blue R-250, N-cyclohexyl-3-aminopropanesulfonic acid (CAPS), 
ethanol, formaldehyde (37%), glycine, hydrochloric acid, 
methanol, potassium chloride, potassium phosphate, silver nitrate, 
sodium bicarbonate, sodium carbonate, sodium dodecyl sulfate 
(SDS), sodium hydroxide, sodium phosphate dibasic, sodium 
phosphate monobasic, sodium thiosulfate, sucrose, N,N,N′,N′-
tetramethylethylenediamine (TEMED), tris(hydroxymethyl)
aminomethane (THAM), and tris(hydroxymethyl)aminomethane 
hydrochloride (Tris-HCl), urea were from Fisher Scientific. 
30% Acrylamide–Bis (37.5 + 1) solution was from Bio-Rad 
Laboratories (Hercules, CA).
(b) Enzymes and inhibitors.—Trypsin from bovine pancreas 
(23.8 kDa), trypsin inhibitor from Glycine max, alpha-
chymotrypsin from bovine pancreas (25 kDa), proteinase K 
(28.9 kDa), and pepsin (35 kDa) were purchased from Sigma-
Aldrich (St. Louis MO).
(c) Protein.—Cry1Ab protein (67 kDa), trypsin-activated, 
salt-free, 96% pure (Case Western Reserve University, 
Cleveland, OH), dissolved in CAPS buffer, 900 μg/L stock 
concentration.
(d) Protein ladder.—PageRuler™ Unstained Broad Range 
Protein Ladder (Fisher Scientific).
(e) Bioassay diet.—Stonefly Heliothis Diet (Ward’s Science, 
Rochester, NY).
Preparation of Solutions
(a) 1 M Tris-HCl.—Weigh 78.8 g Tris-HCl into a 500 mL 
volumetric flask. Dissolve and dilute to 500 mL with water. 
Adjust to pH 6.8 or 8.8 with sodium hydroxide.
(b) 10% SDS.—Weigh 0.1 g SDS into a 1 mL volumetric 
flask. Dissolve and dilute to 1 mL with water.
(c) 10% Ammonium persulfate.—Weigh 0.1 g ammonium 
persulfate into a 1 mL volumetric flask. Dissolve and dilute to 
1 mL with water.
(d) Separating gel.—Combine 2.474 mL acrylamide, 
1.847 mL Tris-HCl pH 8.8, 0.610 mL water, 50 μL 10% SDS, 
4 μL TEMED, and 17 μL 10% ammonium persulfate in a test 
tube. Mix on a vortex mixer. Pour gel between glass plates. 
Overlay the gel with 1 mL butanol. Allow 30–45 min for 
polymerization. Pour off butanol and dry plates.
(e) Stacking gel.—Combine 0.330 mL acrylamide, 0.247 mL 
Tris-HCl pH 6.8, 1.391 mL water, 20 μL 10% SDS, 2 μL 
TEMED, and 10 μL 10% ammonium persulfate in a test tube. 
Mix on a vortex mixer. Place comb between glass plates. Pour 
gel between glass plates on top of the separating gel. Allow 
20–30 min for polymerization.
(f) 0.1% Bromophenol blue.—Weigh 0.1 g bromophenol 
blue into a 100 mL volumetric flask. Dissolve and dilute to 
100 mL with water.
(g) Sample buffer.—Weigh 4 g sucrose and 0.8 g SDS into a 
10 mL volumetric flask. Add 2.5 mL 1 M Tris-HCl (pH 6.8) and 
250 μL 0.1% bromophenol blue. Dilute to 10 mL with water.
(h) Running buffer.—Weigh 3.03 g THAM, 14.42 g glycine, 
and 1 g SDS into a 1 L volumetric flask. Dissolve and dilute to 
1 L with water.
(i) Coomassie stain.—Weigh 1 g Coomassie Brilliant Blue 
into a 1 L volumetric flask. Add 100 mL concentrated acetic 
acid and 400 mL methanol. Dilute to 1 L with water.
(j) Destain solution.—Combine 100 mL concentrated acetic 
acid and 400 mL methanol into a 1 L volumetric flask. Dilute 
to 1 L with water.
(k) 50% Ethanol.—Dilute 500 mL 200 proof ethanol to 1 L 
with water.
(l) 50% Methanol.—Dilute 500 mL methanol to 1 L with 
water.
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(m) Gel fix solution.—Combine 120 mL concentrated acetic 
acid and 500 mL methanol in a 1 L volumetric flask. Dilute to 
1 L with water.
(n) Sodium thiosulfate solution.—Weigh 0.1 g sodium 
thiosulfate into a 500 mL volumetric flask. Dissolve and dilute 
to 500 mL with water.
(o) Silver nitrate solution.—Weigh 1 g silver nitrate into 
a 500 mL volumetric flask. Add 0.375 mL formaldehyde. 
Dissolve and dilute to 500 mL with water.
(p) Developing solution.—Weigh 30 g sodium carbonate 
into a 500 mL volumetric flask. Add 0.25 mL formaldehyde 
and 10 mL sodium thiosulfate solution. Dissolve and dilute to 
500 mL with water.
(q) 50 mM CAPS.—Weigh 1.11 g CAPS into a 100 mL 
volumetric flask. Dissolve and dilute to 100 mL with water. 
Adjust to pH 10.5 with sodium hydroxide.
(r) 20 mM Tris-HCl.—Weigh 1.565 g Tris-HCl into a 
500 mL volumetric flask. Dissolve and dilute to 500 mL with 
water. Adjust to pH 7.5 with sodium hydroxide.
(s) 60 mM Sodium hydroxide.—Weigh 0.24 g sodium 
hydroxide into a 100 mL volumetric flask. Dissolve and dilute 
to 100 mL with water.
(t) Buffer 1: 10 mM phosphate.—Weigh 0.218 g sodium 
phosphate dibasic and 26 mg sodium phosphate monobasic into 
a 100 mL volumetric flask. Dissolve and dilute to 100 mL with 
water. Adjust to pH 7.5 with sodium hydroxide.
(u) Buffer 2: 10 mM Tris-HCl, 1 M urea, and 0.01% SDS.—
Weigh 0.158 g Tris-HCl, 6.01 g urea, and 0.01g SDS into a 
100 mL volumetric flask. Dissolve and dilute to 100 mL with 
water. Adjust to pH 8.5 with sodium hydroxide.
(v) Buffer 3: 0.1 M KH2PO4.—Weigh 1.36 g potassium 
phosphate into a 100 mL volumetric flask. Dissolve and dilute 
to 100 mL with water. Adjust to pH 7.6 with sodium hydroxide 
(for use with trypsin and chymotrypsin) or to pH 1.3 with 
hydrochloric acid (for use with pepsin).
(w) Buffer 4: 98 mM sodium bicarbonate and 2 mM sodium 
carbonate.—Weigh 8.24 g sodium bicarbonate and 21 mg 
sodium carbonate into a 100 mL volumetric flask. Dissolve 
and dilute to 100 mL with water. Adjust to pH 8.0 with sodium 
hydroxide.
(x) Buffer 5: 0.1 M Tris-HCl and 10 mM calcium chloride.—
Weigh 1.576 g Tris-HCl and 0.111 g calcium chloride into a 
100 mL volumetric flask. Dissolve and dilute to 100 mL with 
water. Adjust to pH 7.8 with sodium hydroxide.
(y) Buffer 6: 50 mM HCl.—Dilute 416 μL of concentrated 
hydrochloric acid to 100 mL with water.
(z) Buffer 7: 80 mM HCl-KCl.—Weigh 0.373 g potassium 
chloride into a 100 mL volumetric flask. Add 250 μL 
concentrated hydrochloric acid. Dissolve and dilute to 100 mL 
with water. Adjust to pH 1.5 with hydrochloric acid.
(aa) Trypsin solution.—Weigh 3.2 mg trypsin into a 5 mL 
vial. Dissolve with 2 mL 0.1 M KH2PO4, pH 7.6. This solution, 
when combined with Cry1Ab, results in a trypsin-to-protein 
ratio of 5:1 (mol/mol).
(bb) Trypsin inhibitor solution, 200 μg/mL.—Weigh 1 mg 
trypsin inhibitor into a 5 mL volumetric flask. Dissolve and 
dilute to 5 mL with water.
(cc) Chymotrypsin solution.—Weigh 1.3 mg chymotrypsin 
into a 1 mL volumetric flask. Dissolve and dilute to 1 mL 
with 0.1 M KH2PO4, pH 7.6. This solution, when combined 
with Cry1Ab, results in chymotrypsin-to-protein ratio of 
50:1 (mol/mol). A 5:1 (mol/mol) ratio was prepared by diluting 
0.1 mL of the 50:1 solution to 1 mL with 0.1 M KH2PO4, pH 7.6.
(dd) Proteinase K solution.—Weigh 2 mg proteinase K 
into a 5 mL volumetric flask. Dissolve and dilute to 5 mL with 
20 mM Tris-HCl. This solution, when combined with Cry1Ab, 
results in a proteinase K-to-protein ratio of 1:1 (mol/mol). 
A 0.5:1 (mol/mol) ratio was prepared by diluting 2.5 mL of the 
1:1 solution to 5 mL with 20 mM Tris-HCl.
(ee) Pepsin solution.—Weigh 4.7 mg pepsin into a 1 mL 
volumetric flask. Dissolve and dilute to 5 mL with 0.1 M 
KH2PO4, pH 1.3. This solution, when combined with Cry1Ab, 
results in a pepsin-to-protein ratio of 10:1 (mol/mol). A 
5:1 (mol/mol) ratio was prepared by diluting 0.5 mL of the 10:1 
solution to 1 mL with 0.1 M KH2PO4, pH 1.3. A 1:1 (mol/mol) 
ratio was prepared by diluting 0.1 mL of the 10:1 solution to 
1 mL with 0.1 M KH2PO4, pH 1.3.
Gel Electrophoresis
Polyacrylamide gel electrophoresis with SDS was used to 
screen model systems for production of Cry1Ab fragments. Gels 
were prepared fresh daily according to a previously described 
procedure (8). Samples were prepared for electrophoresis by 
adding an appropriate amount of 4× sample buffer to obtain a 
1× sample buffer concentration. Samples were heated to 100°C 
for 3 to 4 min, chilled in ice for 10 min, and centrifuged at 
12 000 × g for 5 min. Running buffer was added to the upper and 
lower chambers of the apparatus. A 20 μL sample was added to 
each well. Each gel also contained 5 μL PageRuler Unstained 
Broad Range Protein Ladder, with molecular bands ranging 
from 5 to 250 kDa. Gels were run at a constant 180 V until the 
dye front was within 1 cm of the bottom of the gel (approximate 
run times were 1 h). Gels were then removed from the glass 
plates and stained with either Coomassie Brilliant Blue or silver 
stain. Gels were digitized, edited, and annotated.
Coomassie Staining
The Coomassie staining procedure from Rosenberg (8) was 
used. Briefly, gels were stained in Coomassie stain for 30 min 
and destained with destain solution for 2 to 3 h or overnight with 
the destain solution being changed 1 to 2 times. All staining 
steps took place on an orbital shaker at 100 rpm.
Silver Staining
The silver staining procedure also from Rosenberg (8) was 
used. Briefly, after gel electrophoresis, gels were stored in gel 
fix solution overnight. Gels were washed three times with 50% 
ethanol for 20 min each. Gels were then submerged in sodium 
thiosulfate for exactly 1 min and then rinsed with nanopure 
water obtained from a NANOpure® ultra-pure water system 
(Barnstead/Thermolyne, Dubuque, IA) three times for 20 s 
each. Gels were submerged in silver nitrate solution for 20 min 
and rinsed with nanopure water 2 times for 20 s each. Bands 
were visualized by submerging gels in developing solution 
for up to 10 min. The developing process was terminated by 
washing gels with nanopure water twice for 2 min each. Lastly, 
gels were submerged in gel fix solution for 10 min and then in 
50% methanol for 20 min. All steps were performed at room 
temperature on an orbital shaker.
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Bioassays
Insect diet was prepared by mixing one part Stonefly 
Heliothis Diet (Ward’s Science, Rochester, NY) with three parts 
liquid containing treatment or control solution. The diet was 
thoroughly mixed, and 0.3 mL of the diet was placed into each 
well. There were 16 wells per replicate and three replicates per 
treatment (n = 48). One European corn borer (ECB) neonate 
(<8 h old), Ostrinia nubilalis, was placed in each well and 
incubated at 27°C (±2°C) and at 50–65% humidity. ECBs were 
provided by the Corn Insects and Crop Genetics Research 
Unit of the Agricultural Research Service, U.S. Department 
of Agriculture (USDA), Ames, IA. After 7 days, larvae were 
assessed for survival and weight gain. Statistical significance 
(P < 0.05) was determined using an analysis of variance in SAS 
9.3 software (SAS Institute, Cary, NC).
Buffer Determination
A variety of buffers were screened with bioassays to 
determine whether any of the buffer components affected insect 
survival or weight gain. Table 1 (9–16) lists buffer composition 
and enzyme compatibility. A total of seven different buffers 
were tested using the previously described bioassay procedure 
(see Bioassays section).
Trypsin
Trypsin is a serine protease found in the GIT of vertebrate 
and invertebrate animals. Vertebrates such as cattle fed on 
transgenic maize, and invertebrates such as detritivores feeding 
on maize detritus may excrete Cry protein fragments into soil 
and water where they may be detected by ELISAs. Additionally, 
trypsin also acts as a surrogate for other serine proteases, which 
are ubiquitous in eukaryotes and prokaryotes. All enzymes 
were tested using an enzyme-to-toxin (mol/mol) ratio (17). To 
terminate the model system at a specific time point, an inhibitor 
concentration of 200 μg/mL was optimized for use in the model 
system. To ensure that neither the trypsin nor the inhibitor has 
any detrimental effects on insect survival and growth, bioassays 
were performed with a water control, a buffer control, a 5:1 
trypsin solution, a 200 μg/mL inhibitor solution, and the trypsin 
and inhibitor combined, according to the previously described 
bioassay procedure (see Bioassays section).
The trypsin model system consisted of three samples: Cry1Ab 
control, trypsin and inhibitor control, and a treatment (Table 2). 
At termination, 150 μL KH2PO4 (Cry1Ab control) or 150 μL 
200 μg/mL trypsin inhibitor in KH2PO4 buffer [trypsin and 
inhibitor control (treatment)] was added to each vial. Four time 
points were used (10 min and 1, 8, and 24 h), and each sample 
was tested in duplicate for a total of six vials per time point. 
All vials were held at 37°C (optimal for trypsin activity) for the 
duration of the experiment. An additional two Cry1Ab control 
vials held at room temperature also were added for each time 
point to determine whether the elevated temperature produced 
any degradation of the protein. After termination, all samples 
were flash frozen with liquid nitrogen and stored at −80°C until 
analysis with gel electrophoresis.
Chymotrypsin
Like trypsin, chymotrypsin is a serine protease that can act 
as a surrogate for other serine proteases. Chymotrypsin also is 
found in the GIT of vertebrate and invertebrate organisms. To 
ensure that chymotrypsin did not have any detrimental effects 
on insect survival and growth, bioassays were performed with 
a water control, a buffer control, a 50:1 chymotrypsin solution, 
and a 5:1 chymotrypsin solution according to the previously 
described bioassay procedure (see Bioassays section).
The chymotrypsin model system consisted of a Cry1Ab 
control, and a chymotrypsin control and a treatment for each 
of two concentrations of chymotrypsin (50:1 and 5:1 solutions; 
Table 2). No inhibitor was used in the chymotrypsin controls 
or treatments because the presence of the inhibitor would make 
identification of fragments difficult (see Discussion section). 
Instead, inhibition of the samples was achieved by flash-
freezing the samples in liquid nitrogen. Three time points were 
used (1, 8, and 24 h). At termination, 150 μL nanopure water 
was added to each vial. All vials were heated to 37°C for the 
duration of the experiment. After termination, all samples were 
flash-frozen with liquid nitrogen and stored at −80°C until 
analysis with gel electrophoresis.
Proteinase K
Proteinase K is the main proteolytic enzyme found in 
Engyodontium album (formerly Tritirachium album), a fungus 
that has been found in the cysts of soybean plants and associated 
with reeds in wetland areas (18–20). The buffer used for 
proteinase K was a 20 mM Tris-(hydroxymethyl)aminomethane 
hydrochloride (Tris-HCl) buffer, pH 7.5 (21). No inhibitor was 
used for proteinase K; instead, inhibition of the samples was 
achieved by flash-freezing the samples in liquid nitrogen. To 
ensure that neither the buffer nor the proteinase K enzyme 
has any detrimental effects on insect survival and growth, 
bioassays were performed with a water control, a buffer control, 
Table 1. Buffer candidates tested to determine potential effects on ECB larvae
Buffer Composition Enzyme compatibility Refs
1 10 mM Phosphate, pH 7.0–8.0 Trypsin, chymotrypsin (9, 10)
2 1 mM Tris-HCl,1 M urea, and 0.01% (w/v) SDS, pH 8.5 Trypsin (11)
3 0.1 M Potassium phosphate, pH 7.6 Trypsin, chymotrypsin, pepsin (pH 2.0) (12)
4 98 mM Sodium bicarbonate and 2 mM sodium carbonate, pH 8.0 Trypsin, chymotrypsin (13)
5 0.1 M Tris-HCl and 10 mM calcium chloride, pH 7.8 Trypsin, chymotrypsin (14, 15)
6 50 mM HCl Pepsin (15)
7 50 mM KCl and 30 mM HCl, pH 1.5 Pepsin (16)
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and proteinase K solution [proteinase K-to-toxin ratio of 
1:1 (mol/mol) in Tris-HCl buffer] according to the previously 
described bioassay procedure (see Bioassays section).
The proteinase K model system consisted of three samples: 
Cry1Ab control, proteinase K control, and a treatment (Table 2). 
Only one Cry1Ab control and one proteinase K control 
(containing proteinase K and Cry1Ab in a 1:1 ratio) were used 
for each time point, whereas two concentrations of proteinase 
K (a 1:1 ratio and a 0.5:1 ratio) were used in duplicate in the 
treatments. Three time points were used in the experiment 
(15 and 30 min and 1 h). All vials were heated to 37°C for 
the duration of the experiment. At termination for both model 
systems, 150 μL nanopure water was added to each vial. After 
termination, all samples were flash-frozen with liquid nitrogen 
and stored at −80°C until analysis with gel electrophoresis.
Pepsin
Pepsin is a proteolytic enzyme used in many digestibility 
studies and also serves as a surrogate for other aspartate 
proteases found in the environment. To terminate the model 
system at a specific time point, an inhibitory concentration of 
60 mM sodium hydroxide (NaOH) was optimized for use in the 
model system. To ensure that neither the pepsin nor the inhibitor 
has any detrimental effects on insect survival and growth, 
bioassays were performed with a water control, a buffer control 
(KH2PO4, pH 2.2), pepsin solution [pepsin-to-toxin ratio of 
5:1 (mol/mol)], a 60 mM NaOH inhibitor solution, and the 
pepsin and inhibitor combined, according to the previously 
described bioassay procedure (see Bioassays section).
The pepsin model system consisted of four buffer controls, 
a pepsin and inhibitor control, and a treatment (Table 3). Two 
concentrations of pepsin were prepared [pepsin-to-toxin ratio 
of 10:1 and 5:1 (mol/mol)] by dissolving the pepsin in 0.1 M 
KH2PO4, pH 1.3. A more acidic pH than used in the bioassays 
was necessary to compensate for the basic pH of the CAPS 
buffer in which the Cry1Ab protein was dissolved. The final pH 
of the solutions after mixing was 1.64.
In some preliminary experiments (not shown), Cry1Ab was 
degraded in the controls. To determine whether this degradation 
was the result of the acidic buffer or the elevated temperature, 
four buffer controls were used. One control contained 75 μL 
50 mM CAPS, resulting in a basic pH (10.5). The other control 
consisted of 75 μL Cry1Ab solution and 75 μL KH2PO4 
(pH 1.3), resulting in an acidic pH of 1.64, which mimicked 
the treatments. One of each type of control was held at room 
temperature, and another of each was held at 40°C, for a total 
of four buffer controls. All controls were terminated with 
150 μL nanopure water; the subsequent increase in pH resulted 
in termination of the reaction. Samples were held at 40°C. All 
buffer controls were performed singularly, whereas the pepsin 
and inhibitor controls and the treatments were performed in 
duplicate. At termination, 150 μL water or NaOH was added 
(Table 3). After termination, all samples were flash-frozen 
with liquid nitrogen and stored at −80°C until analysis with gel 
electrophoresis.
Table 2. Layout for trypsin, chymotrypsin, and proteinase K model systemsa
Samples Initiation Termination
Trypsin
Cry1Ab control
75 μL KH2PO4
150 μL KH2PO4
75 μL Cry1Ab
Trypsin and inhibitor control
75 μL KH2PO4
150 μL 200 ppm inhibitor solution
75 μL 5:1 trypsin solution in KH2PO4
Treatment
75 μL Cry1Ab
150 μL 200 ppm inhibitor solution
75 μL 5:1 trypsin solution in KH2PO4
Chymotrypsin
Cry1Ab control
75 μL KH2PO4
150 μL water
75 μL Cry1Ab solution
Chymotrypsin control
75 μL KH2PO4
150 μL water
75 μL chymotrypsin solution in KH2PO4
Treatment 75 μL Cry1Ab solution
150 μL water
75 μL chymotrypsin solution in KH2PO4
Proteinase K
Cry1Ab control
75 μL Cry1Ab solution in CAPS
150 μL water
75 μL Tris-HCl
Proteinase K control
75 μL CAPS
150 μL water
75 μL proteinase K solution in Tris-HCl
Treatment
75 μL Cry1Ab solution in CAPS
150 μL water
75 μL proteinase K solution in Tris-HCl
a   At the start of the experiment, the solutions in the initiation column were combined in a vial. All samples were held at 37°C for the specified time 
points. At the end of the experiment, the solution in the termination column was added. All samples were flash-frozen in liquid nitrogen and stored  
at −80°C until analysis. Two levels of chymotrypsin were used in the chymotrypsin model system: chymotrypsin-to-toxin ratios of 50:1 and  
5:1 (mol/mol). Two levels of proteinase K were used in the proteinase K model system: proteinase K-to-toxin ratios of 1:1 and 0.5:1 (mol/mol).
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Based on the results, a second model system was performed 
with pepsin. This model system consisted of a basic and an 
acidic buffer control (described in previous paragraph), three 
pepsin and inhibitor controls [pepsin-to-toxin ratios of 10:1, 5:1, 
and 1:1 (mol/mol)], and three treatments [pepsin-to-toxin ratios 
of 10:1, 5:1, and 1:1 (mol/mol)]. All samples were held at 40°C 
for 30 min or 1 h. Only one replicate was performed for each 
sample. After gel electrophoresis, gels were stained with silver 
stain instead of Coomassie stain. Silver stain was used because 
it is more sensitive than a Coomassie stain and may allow for 
visualization of fragments that are missed by the Coomassie 
stain.
Acidic Buffer
Due to the high degree of fragmentation observed in the acidic 
buffer controls, an acidic buffer model system was investigated 
for its ability to degrade Cry1Ab. Although the preliminary 
results suggested that this model system was useful in generating 
numerous fragments of various sizes, these fragments are 
probably less environmentally relevant than fragments 
generated by other model systems because the acidic conditions 
under which the protein fragmented are not widely found in 
agricultural settings. To ensure that the acidic buffer would 
not have any detrimental effects on insect survival and growth, 
bioassays were performed with a water control and an acidic 
buffer (KH2PO4, pH 1.3) treatment according to the previously 
described bioassay procedure (see Bioassays section).
The first acidic buffer model system consisted of four 
samples and three time points; because this was a range-finding 
study to determine optimal incubation times, no replication was 
performed. One sample contained 75 μL Cry1Ab solution and 
75 μL 50 mM CAPS, resulting in a basic pH (10.5). The other 
sample consisted of 75 μL Cry1Ab solution and 75 μL KH2PO4 
(pH 1.3), resulting in an acidic pH of 1.64. One of each type 
of sample was held at room temperature, and another of each 
was held at 40°C, for a total of four samples per time point. 
All controls were terminated with 150 μL nanopure water at 
24, 36, or 48 h. After termination, all samples were flash-frozen 
with liquid nitrogen and stored at −80°C until analysis with gel 
electrophoresis.
A second acidic buffer model system was evaluated, extending 
the incubation time to 4–7 days. The basic pH samples were 
dropped from the study, leaving only acidic samples at room 
temperature and at 40°C, with the latter being performed in 
duplicate. Samples were terminated with 150 μL nanopure 
water at 4, 5, 6, and 7 days. After termination, all samples were 
flash-frozen with liquid nitrogen and stored at −80°C until 
analysis with gel electrophoresis.
Photodegradation
A model system was set up to use an artificial UV light source. 
This artificial light was generated by using a Rayonet photoreactor. 
This photoreactor uses eight lamps to produce a high-intensity 
light source. Two different model systems were screened: one 
using lamps producing light at 365 nm (±50 nm) and the other 
using lamps producing light at 254 nm. For both model systems, 
1 mL Cry1Ab solution was placed in a Pyrex test tube (for use with 
the 365 nm lamps) or a quartz cuvette (for use with the 254 nm 
lamps). The sample containers were then placed separately into 
the machine on a rotating carousel. A 75 μL aliquot was removed 
and placed in separate 1.5 mL vials at each of the following time 
points: 5, 10, 15, and 30 min, and 1, 2, and 4 h. After collection, 
225 μL nanopure water was added to each vial. A 50 μL aliquot 
was prepared from each sample for gel electrophoresis, and all 
samples were flash-frozen in liquid nitrogen and stored at −80°C 
until analysis by gel electrophoresis and silver staining.
Long-term Degradation in Buffer
A model system was set up to explore degradation of Cry1Ab 
protein over extended periods of time. Unlike previous model 
systems, this system was performed in triplicate. Each sample 
in the model system contained 100 μL Cry1Ab solution and 
100 μL 50 mM CAPS. Four time points were used in the 
study, and there were three replicates per time point: 4, 8, 12, 
and 16 weeks. All samples were stored in the dark at room 
temperature. At termination, 200 μL nanopure water was added 
to each vial, and a 50 μL aliquot was removed and placed in a 
separate vial for gel electrophoresis. All vials were flash-frozen 
with liquid nitrogen and stored at −80°C until analysis by gel 
electrophoresis and silver staining.
Results
Buffer Determination
Only one of the seven buffers (buffer 3) had no significant 
effect on insect survival or average weight gain (Figure 1). Of 
the remaining buffers, buffer 2 caused 100% mortality of the 
ECB larvae, and four buffers significantly decreased average 
Table 3. Layout for pepsin model systema
Samples Initiation Termination
Cry1Ab buffer control (pH 10.5), room temp. 75 μL CAPS and 75 μL Cry1Ab solution 150 μL water
Cry1Ab buffer control (pH 1.64), room temp. 75 μL KH2PO4 and 75 μL Cry1Ab solution 150 μL water
Cry1Ab buffer control (pH 10.5), 40°C 75 μL CAPS and 75 μL Cry1Ab solution 150 μL water
Cry1Ab buffer control (pH 1.64), 40°C 75 μL KH2PO4 and 75 μL Cry1Ab solution 150 μL water
Pepsin and inhibitor control 75 μL Pepsin and 75 μL CAPS 150 μL NaOH
Treatment 75 μL Pepsin and 75 μL Cry1Ab solution 150 μL NaOH
a   At the start of the experiment, the solutions in the initiation column were combined in a vial. Two levels of pepsin were used: pepsin-to-toxin ratios of 
10:1 and 5:1 (mol/mol). One basic and one acidic buffer control were held at room temperature, all other controls and samples were held at 40°C. 
Incubation times for the 10:1 (mol/mol) ratio were 10 and 30 min and 1 and 4 h; incubation times for1 the 5:1 (mol/mol) ratio were 1 and 4 h. At the 
end of the experiment, the solution in the termination column was added. All samples were flash-frozen in liquid nitrogen and stored at −80°C until 
analysis.
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weight gain, whereas one significantly increased average weight 
gain. Buffer 3 was compatible with three of the enzymes to be 
tested, and thus it was used in the trypsin, chymotrypsin, and 
pepsin studies.
Trypsin
The bioassay results suggest that there were no significant 
differences in insect survival due to the presence of trypsin 
or the trypsin inhibitor (Figure 2A). The presence of trypsin 
significantly decreased weight gain in larvae; however, this 
effect was not present in the trypsin and inhibitor treatment, 
indicating that the trypsin inhibitor from Glycine max used in 
the trypsin model system inhibited the activity of trypsin and 
prevented detrimental effects from occurring. Therefore, an 
assumption was made that any significant effects observed 
in bioassays with trypsin-degraded Cry1Ab protein was not 
the result of the presence of trypsin or the trypsin inhibitor. 
No significant degradation of Cry1Ab was observed at any of 
the time points (Figure 3). Some minor degree of degradation 
was observed at 8 and 24 h (Figure 3D) and in some of the 
controls, but this is more likely the result of freeze/thaw cycles 
or naturally occurring degradation over time than presence of 
trypsin. There was no difference between the room temperature 
Cry1Ab controls and the Cry1Ab controls held at 37°C.
Chymotrypsin
Bioassay results indicated that the 50:1 ratio of chymotrypsin 
did not significantly affect insect survival, but it did have 
a significant effect on average weight gain of the larvae 
(Figure 2B). The 5:1 ratio of chymotrypsin did not significantly 
affect survival or average weight of the insects (Figure 2C). A 
similar degradation pattern was observed for both amounts of 
chymotrypsin used at all three time points: decreased amounts 
of parent protein were present and two distinct fragment bands 
were observed (Figure 4A–C). The amount of parent protein 
appeared to decrease between 1 and 24 h. The fragment bands 
also appeared to decrease over time, and no additional fragment 
bands were observed. The chymotrypsin bands also began to 
disappear at 24 h, suggesting that it also is being degraded and 
that longer incubation times would likely be of little use.
Proteinase K
Neither the Tris-HCl buffer nor the proteinase K enzyme 
had any significant effect on insect survival or weight gain 
(Figure 2D). The proteinase K model system produced 
complete degradation of the Cry1Ab protein (Figure 4D–F). 
Using shorter time points and less proteinase K did not affect 
protein degradation. All time points and enzyme concentrations 
produced the same result: a single fragment band around 5 kDa.
Pepsin
The bioassay results indicate that the 5:1 pepsin solution and 
the 60 mM NaOH inhibitor have no effect on insect survival 
either individually or when combined (Figure 2E). The average 
weight of the insects in the buffer control and pepsin-only 
treatments was significantly lower than the water control, 
inhibitor-only, and pepsin and inhibitor combined treatments. 
This is most likely due to the acidic pH values in the diet. The 
average weight of the insects in the inhibitor-only and pepsin and 
inhibitor combined treatments was significantly lower than the 
water control but significantly higher than the buffer-only and 
pepsin-only treatments. The acidity of the inhibitor-only and the 
pepsin and inhibitor combined treatments, although more basic 
than the buffer control and pepsin-only treatments, likely were 
still acidic enough to have negative effects on insect growth.
A 10:1 pepsin concentration completely degraded all the 
Cry1Ab at 30 min and at 1 and 4 h (Figure 5B–D). At 10 min, 
there was significant Cry1Ab degradation, with a little fully 
intact protein remaining (Figure 5A). A 5:1 concentration of 
pepsin also degraded Cry1Ab substantially, leaving only a small 
amount of parent compound (Figure 6A and B). None of the 
time points and pepsin concentration combinations produced 
observable Cry1Ab fragments. However, repeatable degradation 
was observed in the buffer controls with an acidic pH. The 
degree of degradation observed appears to be correlated with 
incubation time: longer time points (Figure 5C and D) exhibited 
more degradation than shorter time points (Figure 5A and B). 
A second model system was performed using one additional 
lower concentration (1:1) and a silver staining technique. As 
with the previous model system, Cry1Ab was substantially 
degraded at all concentrations of pepsin, and small amounts of 
parent compound remained (Figure 6C and D). Although the 
silver staining allowed visualization of more bands on the gel, 
no fragments were observed that could not be accounted for by 
the controls. The acidic buffer controls again showed increasing 
fragmentation of Cry1Ab with increasing incubation time.
Acidic Buffer
The bioassay results suggest that the acidic buffer has no 
significant detrimental effects on insect survival or average 
weight gain (Figure 2F). This is in contrast to the result observed 
in the pepsin preliminary bioassay in which the buffer control 
Figure 1. Buffer determination bioassays. Uppercase letters A and 
B indicate significance within survival across buffers (P = 0.05); 
lowercase letters a–e indicate significance within average weight 
across buffers (P = 0.05). Buffer 1: 10 mM phosphate, pH 7.0-8.0; 
buffer 2: 1 mM Tris-HCl, 1 M urea, and 0.01% (w/v) SDS, pH 8.5; 
buffer 3: 0.1 M potassium phosphate, pH 7.6; buffer 4: 98 mM 
sodium bicarbonate and 2 mM sodium carbonate, pH 8.0; buffer 5: 
0.1 M Tris-HCl and 10 mM calcium chloride, pH 7.8; buffer 6: 50 mM 
HCl; and buffer 7: 50 mM KCl and 30 mM HCl, pH 1.5.
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Figure 2. Bioassays with model system components. (A) Trypsin model system, (B) 50:1 chymotrypsin model system, (C) 5:1 chymotrypsin 
model system, (D) 1:1 proteinase K model system, (E) pepsin model system, and (F) acidic buffer model system. Uppercase letter A indicates 
significance within survival across treatments (P = 0.05); lowercase letters a–c indicate significance within average weight across treatments 
(P = 0.05).
(i.e., same acidic buffer used in this bioassay) significantly 
decreased average weight gain. There is inherent variability 
in any biological system, and increasing the number of insects 
would possibly resolve the issue with this anomaly.
The first attempt at using only an acidic buffer to degrade 
Cry1Ab produced limited fragmentation (Figure 7A and B). 
Almost no degradation was observed in any of the room 
temperature samples. Small amounts of degradation were 
observed in the 40°C samples, with the acidic buffer samples 
exhibiting more degradation than the basic samples. However, a 
substantial amount of parent Cry1Ab still remained. The model 
system was repeated and extended to 4–7 days. These extended 
time points exhibited significant degradation of the protein, with 
nearly all the parent protein completely degraded after 7 days 
(Figure 7C and D). Although there was substantial degradation 
at all four time points, the number of different fragments and the 
quantity of each fragment were low. The most prominent band 
for all samples is a band near 5 kDa.
Photodegradation
In the photodegradation study, no significant degradation 
was observed at any of the time points in the 365 nm treatment 
(Figure 8A). Under harsher conditions with the 254 nm lamps, 
some degradation was observed at the 5, 10, and 15 min time 
points (Figure 8B). However, another phenomenon was also 
observed: at all seven time points, a band larger than 100 kDa 
was observed. By 30 min, all of the fully intact protein had 
dissipated, replaced by substantial quantities of a considerably 
00792-00805.indd   799 13/05/16   1:54 PM
800 Albright et Al.: JournAl of AoAC internAtionAl Vol. 99, no. 3, 2016
Figure 3. Degradation of Cry1Ab with the trypsin model system. Incubation times were (A) 10 min, (B) 1 h, (C) 8 h, and (D) 24 h.
Figure 4. Degradation of Cry1Ab with the chymotrypsin model system and proteinase K model systems. (A–C) Chymotrypsin incubation 
times were (A) 1 h, (B) 8 h, and (C) 24 h. Degradation occurred at all three time points, with only two Cry1Ab fragment bands visualized. 
(D–F) Proteinase K incubation times were (D) 15 min, (E) 30 min, and (F) 1 h. Complete degradation of the protein occurred at all three time 
points, apparently resulting in a single band at 5 kDa.
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larger aggregate and small quantities of a small fragment or 
fragments approximately 5 kDa or smaller in size.
Long-term Degradation
Degradation of the Cry1Ab protein occurred at all time 
points, and there appears to be an increase in quantities of 
the fragments over time (Figure 8C). Substantial amounts of 
the parent protein still remain, even at 16 weeks. There is one 
anomaly: replicate 3 of the 12-week samples underwent more 
degradation than the other two replicates, resulting in additional 
fragments smaller than 15 kDa (Figure 8D). Since a similar 
pattern was not observed in any other samples, this degradation 
is most likely the result of contamination.
Figure 5. Degradation of Cry1Ab with the 10:1 pepsin model system. Incubation times were (A) 10 min, (B) 30 min, (C) 1 h, and (D) 4 h. Pepsin 
rapidly degrades Cry1Ab into a form that is not detectable with gel electrophoresis.
Figure 6. Degradation of Cry1Ab with the pepsin model system. (A, B) Degradation with a 5:1 ratio of pepsin to toxin for (A) 1 h or (B) 4 h. 
(C, D) Degradation of Cry1Ab with the three pepsin model systems for (C) 30 min or (D) 1 h. The two previous pepsin model systems were 
used and a new, third model system was added. Silver staining was used on these model systems in an attempt to detect Cry1Ab fragments 
that may not have been visible with Coomassie staining.
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Discussion
Trypsin did not significantly degrade the Cry1Ab protein 
(Figure 3). Trypsin is one of the proteolytic enzymes present 
in an insect midgut that is responsible for cleaving the Cry1Ab 
protoxin to produce the active form. Because the protein used in 
this study was already activated, it could be expected that further 
degradation would not be observed. This result is supported by 
Díaz-Mendoza et al. (17). In that paper, the authors subjected a 
Cry1Ab protoxin to degradation by three purified trypsins. In all 
three treatments, only a 69 kDa fragment was produced, even 
after 24 h. As a result of these findings, it was determined that a 
trypsin-based model system would not be useful in generating 
Cry1Ab fragments.
Figure 7. Degradation of Cry1Ab with the acidic buffer model system. Incubation times were (A) 24 and 36 h, (B) 48 h, (C) 4 to 5 days, and 
(D) 6 to 7 days. Slight degradation is observed over 24–48 h. Significant degradation occurs over days 4–7, with the protein almost completely 
degraded by day 7, but the number and quantity of fragments does not increase over days 4–7.
Figure 8. Degradation of Cry1Ab with the photodegradation and long-term degradation in buffer model systems. (A, B) Photodegradation 
model system. (A) Degradation with 365 nm light; (B) degradation with 254 nm light. Significant degradation occurs in the samples exposed 
to 254 nm light. (C, D) Long-term degradation in buffer model system. Incubation times were (C) 4 and 8 weeks and (D) 12 and 16 weeks. 
Significant degradation occurs at 12 and 16 weeks, although substantial amounts of parent protein remain.
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Initially, the proteinase K model system included an 
enzyme inhibitor, but challenges in optimizing the inhibitor 
concentration resulted in the exclusion of the inhibitor from 
the model system. Because the samples were flash-frozen with 
liquid nitrogen immediately after termination, the hypothesis 
was that an inhibitor would not be needed. Without the use of 
the inhibitor, all concentrations of proteinase K yielded nearly 
complete degradation of Cry1Ab at all tested time points. 
Changing the incubation time or amount of proteinase K did not 
affect degradation, because the product in all the samples was 
the same: a single band in the 5 kDa range. It is possible that 
the visualized band is not a single 5 kDa fragment, but rather a 
combination of multiple fragments that are 5 kDa or smaller. 
The limitations of the gel mixture used in the current study 
made it impossible to resolve the fragments in more detail; a 
15% gel is ideal for separating and resolving proteins between 
10 and 60 kDa (8). Because the goal of this study was to identify 
model systems that were capable of degrading Cry1Ab into 
fragments, no further work was performed with the fragments 
in the study. Separation and determination of the number of 
fragments present occurred in a subsequent study, in which the 
fragments generated were subjected to bioassays and ELISAs 
to determine whether any of the fragments were still detectable 
and/or whether any bioactivity was retained (22).
Initially, the chymotrypsin model system included an 
inhibitor to stop the enzyme activity; however, the inclusion 
of the inhibitor resulted in the presence of numerous bands on 
the gel that would have made distinguishing Cry1Ab fragments 
from the inhibitor components difficult. After the success 
of the proteinase K model system, in which no inhibitor was 
used, the inhibitor was removed from the chymotrypsin model 
system. Both levels of chymotrypsin significantly degraded 
Cry1Ab, producing two fragments that were visualized by gel 
electrophoresis (Figure 4). Longer time incubations produced 
decreasing amounts of parent Cry1Ab; however, no additional 
fragments were formed. Fragment and chymotrypsin abundance 
also decreased, suggesting further breakdown of both. There 
was no difference in degradation between the chymotrypsin-to-
toxin ratios of 50:1 and 5:1 (mol/mol). This is advantageous 
because it is best to avoid using the 50:1 ratio if possible due 
to the significant growth effects that were observed on insects 
fed a diet containing the higher concentration of chymotrypsin 
(Figure 2B). Further work to determine whether the fragments 
are detectable by ELISAs and whether they retain any bioactivity 
was performed in a subsequent study (22).
Pepsin and its inhibitor had no effect on insect survival 
but did have some effects on weight gain. Although it would 
be ideal for components of a potential model system to have 
no effect on survival and weight gain, it was decided to move 
forward with the pepsin model system to see whether detectable 
fragments could be generated. Ultimately, it did not matter 
that weight gain of the insects was affected, because pepsin 
significantly degraded Cry1Ab but yielded no fragments 
that were detectable by gel electrophoresis. This effect was 
consistently observed despite numerous attempts to alter pepsin 
concentration and reduce incubation time (Figure 6). A change 
in staining technique from a Coomassie stain to a more sensitive 
silver stain produced additional bands in the controls but did 
not generate any Cry1Ab fragments that were detectable by gel 
electrophoresis.
The current hypothesis is that pepsin (which cleaves between 
hydrophobic amino acids, such as tyrosine and phenylalanine) 
rapidly degrades Cry1Ab into amino acids or very small 
fragments that are not detectable by gel electrophoresis. This 
is most apparent at shorter time points (Figures 5 and 6) at 
which fully intact Cry1Ab protein remains, but no intermediate 
fragments are observed. As a result of these findings, it was 
determined that a pepsin-based model system would not be 
useful in generating Cry1Ab fragments. However, there were 
varying degrees of Cry1Ab degradation observed in the acidic 
buffer controls, suggesting that a model system based on an 
acidic buffer alone may be suitable for fragmenting Cry1Ab. 
Other simulated gastric systems were considered for their 
potential to degrade Cry1Ab. However, no model systems based 
on gastric fluids were tested because most gastric systems use 
pepsin as the prominent enzyme (23–25).
An acidic buffer model system was tested over a range of 
incubation times to determine whether prolonged exposure to an 
acidic environment would result in Cry1Ab degradation. Longer 
time points (4–7 days) were the best intervals at generating 
fragments of Cry1Ab. The acidic buffer model system produced 
the highest number of different fragments (4–8 bands on the gel; 
Figure 7). Some parent Cry1Ab still remained after 4–7 days. 
This parent protein should still be detectable by ELISAs and 
have bioactivity; however, a decrease in absorbance (in the 
ELISAs) and bioactivity should be observed if the fragments are 
not detectable by ELISA. Further work is needed to determine 
the number of fragments present (particularly in the band near 
5 kDa). This was performed in a subsequent study, which 
determined whether the fragments were detectable by ELISAs 
and whether any bioactivity was retained by the fragments (22).
An attempt to use UV light to degrade Cry1Ab used a 
photoreactor and two different wavelengths of light (365 and 
254 nm). Degradation of proteins (including Cry proteins) 
subjected to UV light is known to occur, with cysteine, 
phenylalanine, tryptophan, and tyrosine being the primary 
sites of photodegradation (26, 27). The initial focus was on the 
365 nm wavelength because it produces light within the natural 
solar spectrum and provides the most relevant results (28). 
No degradation was observed at this wavelength (Figure 8A). 
This was unexpected because there are numerous reports of 
formulations of B. thuringiensis insecticide (Bt) being inactivated 
under natural sunlight (29, 30). The most likely explanation for 
this is that this study used pure Cry1Ab protein. Pure protein does 
not degrade readily in sunlight because the highest absorption 
band of the pure protein is in the 280–285 nm range; the solar 
spectrum decreases to zero intensity in the 300–305 nm range 
(28). Cry proteins in Bt insecticide formulations degrade 
readily in sunlight because the formulations often contain 
cofactors, prosthetic groups, or other adjuvants that can act as 
chromophores to capture photons and transfer energy to the Cry 
protein, resulting in its degradation (26, 28).
Because no degradation was observed at 365 nm, a harsher 
UV treatment (254 nm) was used. Although this wavelength 
does not occur in the solar spectrum, it may provide clues about 
how Cry1Ab degrades under natural sunlight. Degradation of 
Cry1Ab occurs rapidly at 254 nm, with fragments visible after 
only 5 min (Figure 8B). However, exposure to UV light at 
254 nm also appears to have other unintended consequences. 
At all time points, a majority of the protein was converted into a 
molecule greater than 100 kDa, and by 30 min, nearly all of the 
protein was in this form. The most likely explanation is that the 
UV light caused the fully intact protein and/or protein fragments 
to become cross-linked to each other, forming dimers and other 
00792-00805.indd   803 13/05/16   1:54 PM
804 Albright et Al.: JournAl of AoAC internAtionAl Vol. 99, no. 3, 2016
types of aggregate molecules; such protein–protein cross-
linking is known to occur at 254 nm (31). It is unknown whether 
the presence of these dimers/polymers will lead to a potential 
increase or decrease in toxicity or whether the aggregates are 
even detectable by ELISA. Despite the presence of cross-linked 
protein, a UV photodegradation model system is capable of 
generating some fragments of Cry1Ab protein. Further research 
in a subsequent study used shorter time points to determine 
whether the fragments and/or dimers were still detectable by 
ELISA and whether they retained any bioactivity (22).
Long-term degradation of Cry1Ab protein in CAPS buffer 
yielded low to moderate amounts of degradation, with substantial 
amounts of parent protein remaining, even after 16 weeks in the 
laboratory at room temperature (Figure 8C and D). This finding 
is in contrast to other studies in which Cry1Ab was reported to 
have half-lives of a few days (32–34). However, these studies 
were performed in biologically active soil and water samples 
in which microbes and other organisms are available to assist 
in the degradation of the protein. Although the model system 
components were not sterilized at the start of the experiment, 
there was no visual evidence that such organisms were present 
in the course of the study (i.e., the solution remained clear, 
and no algal or microbial films were observed on the surface 
of the solutions or the glassware). The 16-week samples were 
determined to exhibit substantial degradation. Further work 
to determine whether the fragments are detectable by ELISAs 
and whether they retain any bioactivity was performed in a 
subsequent study (22).
Conclusions
Multiple approaches were used in attempts to degrade 
Cry1Ab into environmentally relevant fragments. Five model 
systems were identified that could reliably generate Cry1Ab 
fragments. These five systems—the chymotrypsin, proteinase 
K, acidic buffer, photodegradation, and long-term degradation 
model systems—were used in a subsequent study to determine 
whether fragmented proteins generated in environmental 
matrixes were still detectable by ELISAs and whether they 
retained any bioactivity.
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